Skip to main content
Annals of Surgery logoLink to Annals of Surgery
. 1993 May;217(5):439–446. doi: 10.1097/00000658-199305010-00003

Neurotensin regulates growth of human pancreatic cancer.

J Ishizuka 1, C M Townsend Jr 1, J C Thompson 1
PMCID: PMC1242817  PMID: 8387763

Abstract

OBJECTIVE: The effect of neurotensin (NT) on in vitro-growth of human pancreatic cancer cells (MIA PaCa-2) was examined. Furthermore, the intracellular signal-transduction pathways by which neurotensin regulates growth of MIA PaCa-2 cells were determined. SUMMARY BACKGROUND DATA: NT is trophic for normal rat pancreas, but the effect of NT on growth of human pancreatic cancer is not known. METHODS: Effects of NT (10(-12) to 10(-6) mol/l) on growth of MIA PaCa-2 cells were determined by both count of cell numbers and 3H-thymidine incorporation. Action of NT on phosphatidylinositol (PI) hydrolysis, cyclic AMP production, and intracellular calcium level were determined by conventional methods. The effects of 8-bromo-cyclic AMP and prostaglandin E2 on cell growth were determined. RESULTS: Low concentrations of NT (10(-12) to 10(-9) mol/l) stimulated growth in a dose-dependent manner, but higher concentrations of NT (10(-8) to 10(-6) mol/l) did not stimulate growth of MIA PaCa-2 cells. NT (10(-12) to 10(-6) mol/l) stimulated PI hydrolysis and increased intracellular calcium levels in a dose-dependent manner. High concentrations of NT (10(-8) to 10(-6) mol/l) stimulated production of cyclic AMP in a dose-dependent manner. 8-bromo-cyclic AMP inhibited growth of MIA PaCa-2 cells; prostaglandin E2 did not affect growth of MIA PaCa-2 cells. CONCLUSIONS: NT stimulates growth of MIA PaCa-2 cells through stimulation of PI hydrolysis and mobilization of calcium. Stimulation of the cyclic AMP pathway by high concentrations of NT abolishes the growth-stimulatory effect of NT that is mediated through PI hydrolysis or calcium mobilization.

Full text

PDF
445

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amar S., Kitabgi P., Vincent J. P. Activation of phosphatidylinositol turnover by neurotensin receptors in the human colonic adenocarcinoma cell line HT29. FEBS Lett. 1986 May 26;201(1):31–36. doi: 10.1016/0014-5793(86)80565-8. [DOI] [PubMed] [Google Scholar]
  2. Amar S., Kitabgi P., Vincent J. P. Stimulation of inositol phosphate production by neurotensin in neuroblastoma N1E115 cells: implication of GTP-binding proteins and relationship with the cyclic GMP response. J Neurochem. 1987 Oct;49(4):999–1006. doi: 10.1111/j.1471-4159.1987.tb09986.x. [DOI] [PubMed] [Google Scholar]
  3. Andersson S., Rosell S., Hjelmquist U., Chang D., Folkers K. Inhibition of gastric and intestinal motor activity in dogs by (Gln4) neurotensin. Acta Physiol Scand. 1977 Jun;100(2):231–235. doi: 10.1111/j.1748-1716.1977.tb05941.x. [DOI] [PubMed] [Google Scholar]
  4. Berridge M. J., Irvine R. F. Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature. 1984 Nov 22;312(5992):315–321. doi: 10.1038/312315a0. [DOI] [PubMed] [Google Scholar]
  5. Boring C. C., Squires T. S., Tong T. Cancer statistics, 1992. CA Cancer J Clin. 1992 Jan-Feb;42(1):19–38. doi: 10.3322/canjclin.42.1.19. [DOI] [PubMed] [Google Scholar]
  6. Bozou J. C., Rochet N., Magnaldo I., Vincent J. P., Kitabgi P. Neurotensin stimulates inositol trisphosphate-mediated calcium mobilization but not protein kinase C activation in HT29 cells. Involvement of a G-protein. Biochem J. 1989 Dec 15;264(3):871–878. doi: 10.1042/bj2640871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Carraway R., Leeman S. E. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J Biol Chem. 1973 Oct 10;248(19):6854–6861. [PubMed] [Google Scholar]
  8. Connolly M. M., Dawson P. J., Michelassi F., Moossa A. R., Lowenstein F. Survival in 1001 patients with carcinoma of the pancreas. Ann Surg. 1987 Sep;206(3):366–373. doi: 10.1097/00000658-198709000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Davis T. P., Burgess H. S., Crowell S., Moody T. W., Culling-Berglund A., Liu R. H. Beta-endorphin and neurotensin stimulate in vitro clonal growth of human SCLC cells. Eur J Pharmacol. 1989 Feb 28;161(2-3):283–285. doi: 10.1016/0014-2999(89)90862-5. [DOI] [PubMed] [Google Scholar]
  10. Doyle H., Greeley G. H., Jr, Mate L., Sakamoto T., Townsend C. M., Jr, Thompson J. C. Distribution of neurotensin in the canine gastrointestinal tract. Surgery. 1985 Mar;97(3):337–341. [PubMed] [Google Scholar]
  11. Evers B. M., Izukura M., Chung D. H., Parekh D., Yoshinaga K., Greeley G. H., Jr, Uchida T., Townsend C. M., Jr, Thompson J. C. Neurotensin stimulates growth of colonic mucosa in young and aged rats. Gastroenterology. 1992 Jul;103(1):86–91. doi: 10.1016/0016-5085(92)91099-p. [DOI] [PubMed] [Google Scholar]
  12. Evers B. M., Izukura M., Townsend C. M., Jr, Uchida T., Thompson J. C. Differential effects of gut hormones on pancreatic and intestinal growth during administration of an elemental diet. Ann Surg. 1990 May;211(5):630–638. [PMC free article] [PubMed] [Google Scholar]
  13. Evers B. M., Izukura M., Townsend C. M., Jr, Uchida T., Thompson J. C. Neurotensin prevents intestinal mucosal hypoplasia in rats fed an elemental diet. Dig Dis Sci. 1992 Mar;37(3):426–431. doi: 10.1007/BF01307738. [DOI] [PubMed] [Google Scholar]
  14. Feurle G. E., Müller B., Rix E. Neurotensin induces hyperplasia of the pancreas and growth of the gastric antrum in rats. Gut. 1987;28 (Suppl):19–23. doi: 10.1136/gut.28.suppl.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fontaine J., Lebrun P. Effects of neurotensin on the isolated mouse distal colon. Eur J Pharmacol. 1985 Jan 2;107(2):141–147. doi: 10.1016/0014-2999(85)90052-4. [DOI] [PubMed] [Google Scholar]
  16. Grynkiewicz G., Poenie M., Tsien R. Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985 Mar 25;260(6):3440–3450. [PubMed] [Google Scholar]
  17. Hoosein N. M., Black B. E., Brattain D. E., Brattain M. G. Promotion of differentiation in human colon carcinoma cells by vasoactive intestinal polypeptide. Regul Pept. 1989 Jan;24(1):15–26. doi: 10.1016/0167-0115(89)90207-3. [DOI] [PubMed] [Google Scholar]
  18. Ishizuka J., Beauchamp R. D., Townsend C. M., Jr, Greeley G. H., Jr, Thompson J. C. Receptor-mediated autocrine growth-stimulatory effect of 5-hydroxytryptamine on cultured human pancreatic carcinoid cells. J Cell Physiol. 1992 Jan;150(1):1–7. doi: 10.1002/jcp.1041500102. [DOI] [PubMed] [Google Scholar]
  19. Ishizuka J., Martinez J., Townsend C. M., Jr, Thompson J. C. The effect of gastrin on growth of human stomach cancer cells. Ann Surg. 1992 May;215(5):528–534. doi: 10.1097/00000658-199205000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kim S. W., Beauchamp R. D., Townsend C. M., Jr, Thompson J. C. Vasoactive intestinal polypeptide inhibits c-myc expression and growth of human gastric carcinoma cells. Surgery. 1991 Aug;110(2):270–276. [PubMed] [Google Scholar]
  21. Kitabgi P., Kwan C. Y., Fox J. E., Vincent J. P. Characterization of neurotensin binding to rat gastric smooth muscle receptor sites. Peptides. 1984 Sep-Oct;5(5):917–923. doi: 10.1016/0196-9781(84)90117-7. [DOI] [PubMed] [Google Scholar]
  22. Mazella J., Kitabgi P., Vincent J. P. Molecular properties of neurotensin receptors in rat brain. Identification of subunits by covalent labeling. J Biol Chem. 1985 Jan 10;260(1):508–514. [PubMed] [Google Scholar]
  23. Millar J. B., Rozengurt E. Bombesin enhancement of cAMP accumulation in Swiss 3T3 cells: evidence of a dual mechanism of action. J Cell Physiol. 1988 Nov;137(2):214–222. doi: 10.1002/jcp.1041370203. [DOI] [PubMed] [Google Scholar]
  24. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature. 1984 Apr 19;308(5961):693–698. doi: 10.1038/308693a0. [DOI] [PubMed] [Google Scholar]
  25. Polak J. M., Sullivan S. N., Bloom S. R., Buchan A. M., Facer P., Brown M. R., Pearse A. G. Specific localisation of neurotensin to the N cell in human intestine by radioimmunoassay and immunocytochemistry. Nature. 1977 Nov 10;270(5633):183–184. doi: 10.1038/270183a0. [DOI] [PubMed] [Google Scholar]
  26. Rozengurt E. Early signals in the mitogenic response. Science. 1986 Oct 10;234(4773):161–166. doi: 10.1126/science.3018928. [DOI] [PubMed] [Google Scholar]
  27. Rozengurt E. Neuropeptides as cellular growth factors: role of multiple signalling pathways. Eur J Clin Invest. 1991 Apr;21(2):123–134. doi: 10.1111/j.1365-2362.1991.tb01801.x. [DOI] [PubMed] [Google Scholar]
  28. Sakamoto T., Newman J., Fujimura M., Greeley G. H., Jr, Townsend C. M., Jr, Thompson J. C. Role of neurotensin in pancreatic secretion. Surgery. 1984 Aug;96(2):146–153. [PubMed] [Google Scholar]
  29. Sethi T., Langdon S., Smyth J., Rozengurt E. Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo. Cancer Res. 1992 May 1;52(9 Suppl):2737s–2742s. [PubMed] [Google Scholar]
  30. Sethi T., Rozengurt E. Multiple neuropeptides stimulate clonal growth of small cell lung cancer: effects of bradykinin, vasopressin, cholecystokinin, galanin, and neurotensin. Cancer Res. 1991 Jul 1;51(13):3621–3623. [PubMed] [Google Scholar]
  31. Seuwen K., Magnaldo I., Pouysségur J. Serotonin stimulates DNA synthesis in fibroblasts acting through 5-HT1B receptors coupled to a Gi-protein. Nature. 1988 Sep 15;335(6187):254–256. doi: 10.1038/335254a0. [DOI] [PubMed] [Google Scholar]
  32. Staley J., Fiskum G., Davis T. P., Moody T. W. Neurotensin elevates cytosolic calcium in small cell lung cancer cells. Peptides. 1989 Nov-Dec;10(6):1217–1221. doi: 10.1016/0196-9781(89)90015-6. [DOI] [PubMed] [Google Scholar]
  33. Thor K., Rosell S. Neurotensin increases colonic motility. Gastroenterology. 1986 Jan;90(1):27–31. doi: 10.1016/0016-5085(86)90070-3. [DOI] [PubMed] [Google Scholar]
  34. Tihon C., Goren M. B., Spitz E., Rickenberg H. V. Convenient elimination of trichloroacetic acid prior to radioimmunoassay of cyclic nucleotides. Anal Biochem. 1977 Jun;80(2):652–653. doi: 10.1016/0003-2697(77)90693-5. [DOI] [PubMed] [Google Scholar]
  35. Turner J. T., James-Kracke M. R., Camden J. M. Regulation of the neurotensin receptor and intracellular calcium mobilization in HT29 cells. J Pharmacol Exp Ther. 1990 Jun;253(3):1049–1056. [PubMed] [Google Scholar]
  36. Wood J. G., Hoang H. D., Bussjaeger L. J., Solomon T. E. Effect of neurotensin on pancreatic and gastric secretion and growth in rats. Pancreas. 1988;3(3):332–339. doi: 10.1097/00006676-198805000-00015. [DOI] [PubMed] [Google Scholar]
  37. Wood J. G., Hoang H. D., Bussjaeger L. J., Solomon T. E. Neurotensin stimulates growth of small intestine in rats. Am J Physiol. 1988 Dec;255(6 Pt 1):G813–G817. doi: 10.1152/ajpgi.1988.255.6.G813. [DOI] [PubMed] [Google Scholar]
  38. Zurier R. B., Kozma M., Sinnett-Smith J., Rozengurt E. Vasoactive intestinal peptide synergistically stimulates DNA synthesis in mouse 3T3 cells: role of cAMP, Ca2+, and protein kinase C. Exp Cell Res. 1988 May;176(1):155–161. doi: 10.1016/0014-4827(88)90129-2. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES